Press Release Title Background

Nuclear Imaging Devices Market to Grow at a CAGR of 4.38% During 2025 to 2035; Driven by Increasing Demand for Advanced Diagnostic Imaging Technologies

Report Details:
15 Companies Covered
200 Pages

Market Highlights


Nuclear Imaging Devices Market Size was valued at USD 1.98 Billion in 2024 & the market is projected to grow from USD 2.067 Billion in 2025 to USD 3.174 Billion by 2035, registering a CAGR of 4.38% during the forecast period 2025–2035. North America led the market with over 45.45% share, generating around USD 0.9 Billion in revenue.


The global nuclear imaging devices market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 2.80 billion by 2032, and is projected to register a CAGR of 5.1% over the forecast period.


Various other factors such as the advancements in radiotracers, acceptance of nuclear imaging devices in ambulatory settings, increasing geriatric population, untapped emerging markets, rise in regulatory approvals, and increasing investment on diagnostic imaging centers are also expected to propel the growth of the market.


However, the high cost of the nuclear imaging device, shorter half-life of radiopharmaceuticals can hamper market growth over the forecast period.


Segmentation


The global nuclear imaging devices market is segmented based on technology, application, end user, and region.


The global market for nuclear imaging devices, by technology, is segmented into positron emission tomography (PET), single photon emission computed tomography (SPECT), and planar scintigraphy. The single-photon-emission computed tomography (SPECT) are further classified as hybrid SPECT systems and standalone SPECT systems.


Based on application, the market is segmented into oncology, cardiology, neurology, and others.


Based on end user, the market is segmented into hospitals, diagnostic imaging centers, and others.


The diagnostic imaging centers segment is expected to witness the fastest growth over the forecast period due to rising adoption of nuclear imaging in diagnostic centers.


Key Players


Some of the key players in the global nuclear imaging devices market are Philips Healthcare, Digirad Corporation, Neusoft Medical Systems Co., Ltd., Progenics Pharmaceuticals Inc., Cannon Inc., Surgiceye GmbH, CMR Naviscan, Mediso Medical Imaging Systems Ltd., Agfa-Gevaert Group, General Electric Company, DDD-Diagnostic A/S, Spectrum Dynamics Medical, FMI Medical Systems, Inc., Segamicorp, and others.


Nuclear Imaging Devices Market Regional Analysis


In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.


The nuclear imaging devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European nuclear imaging devices market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The nuclear imaging devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The nuclear imaging devices market in the Middle East & Africa has been segmented into the Middle East and Africa.